logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Richard F Schuman

This inventor holds 15 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Longhorn Vaccines and Diagnostics, LLC, Biosynexus, Inc., The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard F Schuman. Retrieved from https://idiyas.com/inventor/richard-f-schuman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 46.7


Average Co-Inventor Count = 3.5

ph-index = 6

Forward Citations = 143(Granted Patents)


Location History:

  • North Potomac, MD (US) (2006)
  • Rockville, MD (US) (2009)
  • Gaithersburg, MD (US) (2003 - 2013)
  • Silver Spring, MD (US) (2019 - 2020)
  • Boyds, MD (US) (2017 - 2023)

Company Filing History:

goldMedal5 out of 39 
 
Longhorn Vaccines and Diagnostics, LLC
 patents
silverMedal4 out of 13 
 
Biosynexus, Inc.
 patents
bronzeMedal3 out of 196 
 
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
 patents
4. 2 out of 61 
 
Altor Bioscience Corporation
 patents
5. 2 out of 8,753 
 
US Government as Represented by the Secretary of the Army
 patents
6. 1 out of 11 
 
Sunol Molecular Corporation
 patents
7. 1 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 2003-2023

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 11717561 - Multimodal antimicrobial therapy (2023-08-08),
2. 10787504 - Antibodies that modulate immunity to drug resistant and latent MTB infections (2020-09-29),
3. 10414819 - Monoclonal antibodies that modulate immunity to MTB and enhance immune clearance (2019-09-17),
4. 10370437 - Antibodies that modulate immunity to drug resistant and latent MTB infections (2019-08-06),
5. 9814766 - Multimodal antimicrobial therapy (2017-11-14),
6. 8372958 - Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria (2013-02-12),
7. 7884198 - Polynucleotides encoding humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria (2011-02-08),
8. 7777017 - Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria (2010-08-17),
9. 7566540 - [object Object] (2009-07-28),
10. 7511122 - Humanized and chimeric antibodies specific for lipoteichoic acid of GRAM positive bacteria (2009-03-31),
11. 7250494 - Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria (2007-07-31),
12. 7169903 - Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria (2007-01-30),
13. 7094883 - Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein (2006-08-22),
14. 6939543 - Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria (2005-09-06),
15. 6610293 - Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria (2003-08-26),

Title: The Innovative Journey of Richard F. Schuman

Introduction: Richard F. Schuman is a renowned inventor based in Gaithersburg, MD, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Richard F. Schuman holds several patents in various technological domains, including advancements in renewable energy systems and sustainable technologies.

Career Highlights: With a career spanning over two decades, Richard F. Schuman has been at the forefront of developing cutting-edge solutions for environmental challenges, earning recognition for his pioneering work in the industry.

Collaborations: Throughout his career, Richard F. Schuman has collaborated with leading research institutions, universities, and innovative companies to further his mission of creating a more sustainable future through technology.

Conclusion: Richard F. Schuman's dedication to innovation and sustainability has not only shaped the technological landscape but has also inspired future generations of inventors to push the boundaries of what is possible in the realm of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…